Works by Kordasiewicz, Holly B


Results: 20
    1

    MicroRNA Profiling Reveals Marker of Motor Neuron Disease in ALS Models.

    Published in:
    Journal of Neuroscience, 2017, v. 37, n. 22, p. 5574, doi. 10.1523/JNEUROSCI.3582-16.2017
    By:
    • Hoye, Mariah L.;
    • Koval, Erica D.;
    • Wegener, Amy J.;
    • Hyman, Theodore S.;
    • Chengran Yang;
    • O'Brien, David R.;
    • Miller, Rebecca L.;
    • Cole, Tracy;
    • Schoch, Kathleen M.;
    • Tao Shen;
    • Tomonori Kunikata;
    • Richard, Jean-Philippe;
    • Gutmann, David H.;
    • Maragakis, Nicholas J.;
    • Kordasiewicz, Holly B.;
    • Dougherty, Joseph D.;
    • Miller, Timothy M.
    Publication type:
    Article
    2
    3
    4
    5
    6

    Antisense oligonucleotide–mediated MSH3 suppression reduces somatic CAG repeat expansion in Huntington's disease iPSC–derived striatal neurons.

    Published in:
    Science Translational Medicine, 2025, v. 17, n. 785, p. 1, doi. 10.1126/scitranslmed.adn4600
    By:
    • Bunting, Emma L.;
    • Donaldson, Jasmine;
    • Cumming, Sarah A.;
    • Olive, Jessica;
    • Broom, Elizabeth;
    • Miclăuș, Mihai;
    • Hamilton, Joseph;
    • Tegtmeyer, Matthew;
    • Zhao, Hien T.;
    • Brenton, Jonathan;
    • Lee, Won-Seok;
    • Handsaker, Robert E.;
    • Li, Susan;
    • Ford, Brittany;
    • Ryten, Mina;
    • McCarroll, Steven A.;
    • Kordasiewicz, Holly B.;
    • Monckton, Darren G.;
    • Balmus, Gabriel;
    • Flower, Michael
    Publication type:
    Article
    7
    8

    Huntingtin suppression restores cognitive function in a mouse model of Huntington disease.

    Published in:
    Science Translational Medicine, 2018, v. 10, n. 461, p. 1, doi. 10.1126/scitranslmed.aar3959
    By:
    • Southwell, Amber L.;
    • Kordasiewicz, Holly B.;
    • Langbehn, Douglas;
    • Skotte, Niels H.;
    • Parsons, Matthew P.;
    • Villanueva, Erika B.;
    • Caron, Nicholas S.;
    • Østergaard, Michael E.;
    • Anderson, Lisa M.;
    • Xie, Yuanyun;
    • Cengio, Louisa Dal;
    • Findlay-Black, Hailey;
    • Doty, Crystal N.;
    • Fitsimmons, Bethany;
    • Swayze, Eric E.;
    • Seth, Punit P.;
    • Raymond, Lynn A.;
    • Frank Bennett, C.;
    • Hayden, Michael R.
    Publication type:
    Article
    9

    Tau reduction prevents neuronal loss and reverses pathological tau deposition and seeding in mice with tauopathy.

    Published in:
    Science Translational Medicine, 2017, v. 9, n. 374, p. 1, doi. 10.1126/scitranslmed.aag0481
    By:
    • DeVos, Sarah L.;
    • Miller, Rebecca L.;
    • Schoch, Kathleen M.;
    • Holmes, Brandon B.;
    • Kebodeaux, Carey S.;
    • Wegener, Amy J.;
    • Guo Chen;
    • Tao Shen;
    • Tran, Hien;
    • Nichols, Brandon;
    • Zanardi, Tom A.;
    • Kordasiewicz, Holly B.;
    • Swayze, Eric E.;
    • Bennett, C. Frank;
    • Diamond, Marc I.;
    • Miller, Timothy M.
    Publication type:
    Article
    10

    Peripheral huntingtin silencing does not ameliorate central signs of disease in the B6.Htt<sup>Q111/+</sup> mouse model of Huntington’s disease.

    Published in:
    PLoS ONE, 2017, v. 12, n. 4, p. 1, doi. 10.1371/journal.pone.0175968
    By:
    • Coffey, Sydney R.;
    • Bragg, Robert M.;
    • Minnig, Shawn;
    • Ament, Seth A.;
    • Cantle, Jeffrey P.;
    • Glickenhaus, Anne;
    • Shelnut, Daniel;
    • Carrillo, José M.;
    • Shuttleworth, Dominic D.;
    • Rodier, Julie-Anne;
    • Noguchi, Kimihiro;
    • Bennett, C. Frank;
    • Price, Nathan D.;
    • Kordasiewicz, Holly B.;
    • Carroll, Jeffrey B.
    Publication type:
    Article
    11

    In Vivo Evaluation of Candidate Allele-specific Mutant Huntingtin Gene Silencing Antisense Oligonucleotides.

    Published in:
    Molecular Therapy, 2014, v. 22, n. 12, p. 2093, doi. 10.1038/mt.2014.153
    By:
    • Southwell, Amber L;
    • Skotte, Niels H;
    • Kordasiewicz, Holly B;
    • Østergaard, Michael E;
    • Watt, Andrew T;
    • Carroll, Jeffrey B;
    • Doty, Crystal N;
    • Villanueva, Erika B;
    • Petoukhov, Eugenia;
    • Vaid, Kuljeet;
    • Xie, Yuanyun;
    • Freier, Susan M;
    • Swayze, Eric E;
    • Seth, Punit P;
    • Bennett, Clarence Frank;
    • Hayden, Michael R
    Publication type:
    Article
    12
    13

    A single-cell map of antisense oligonucleotide activity in the brain.

    Published in:
    Nucleic Acids Research, 2023, v. 51, n. 14, p. 7109, doi. 10.1093/nar/gkad371
    By:
    • Mortberg, Meredith A;
    • Gentile, Juliana E;
    • Nadaf, Naeem M;
    • Vanderburg, Charles;
    • Simmons, Sean;
    • Dubinsky, Dan;
    • Slamin, Adam;
    • Maldonado, Salome;
    • Petersen, Caroline L;
    • Jones, Nichole;
    • Kordasiewicz, Holly B;
    • Zhao, Hien T;
    • Vallabh, Sonia M;
    • Minikel, Eric Vallabh
    Publication type:
    Article
    14
    15
    16

    Protein production is an early biomarker for RNA‐targeted therapies.

    Published in:
    Annals of Clinical & Translational Neurology, 2018, v. 5, n. 12, p. 1492, doi. 10.1002/acn3.657
    By:
    • Self, Wade K.;
    • Schoch, Kathleen M.;
    • Alex, Jacob;
    • Barthélemy, Nicolas;
    • Bollinger, James G.;
    • Sato, Chihiro;
    • Cole, Tracy;
    • Kordasiewicz, Holly B.;
    • Swayze, Eric;
    • Bateman, Randall J.;
    • Miller, Timothy M.
    Publication type:
    Article
    17

    Results of the first‐in‐human, randomized, double‐blind, placebo‐controlled phase 1b study of lumbar intrathecal bolus administrations of antisense oligonucleotide (ISIS 814907; BIIB080) targeting tau mRNA in patients with mild Alzheimer's disease

    Published in:
    Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.051871
    By:
    • Mummery, Catherine J;
    • Junge, Candice;
    • Kordasiewicz, Holly B;
    • Mignon, Laurence;
    • Moore, Katrina M;
    • Yun, Chris;
    • Baumann, Tiffany L;
    • Li, Dan;
    • Norris, Daniel A;
    • Crean, Rebecca;
    • Graham, Danielle;
    • Huang, Ellen;
    • Ratti, Elena;
    • Lane, Roger M
    Publication type:
    Article
    18

    DISCOVERY AND EARLY CLINICAL DEVELOPMENT OF IONIS-MAPTRX, THE FIRST TAU-LOWERING ANTISENSE OLIGONUCLEOTIDE, IN PATIENTS WITH MILD AD.

    Published in:
    Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P600, doi. 10.1016/j.jalz.2017.07.242
    By:
    • Lane, Roger M.;
    • Kordasiewicz, Holly B.;
    • Smith, Anne;
    • Mignon, Laurence;
    • Miller, Timothy M.;
    • Mummery, Catherine J.;
    • Andreasen, Niels;
    • Narayanan, Padma;
    • Swayze, Eric;
    • Norris, Daniel A.;
    • Fitzsimmons, Bethany;
    • Bennett, C Frank
    Publication type:
    Article
    19

    A novel humanized mouse model of Huntington disease for preclinical development of therapeutics targeting mutant huntingtin alleles.

    Published in:
    Human Molecular Genetics, 2017, v. 26, n. 6, p. 1115, doi. 10.1093/hmg/ddx021
    By:
    • Southwell, Amber L.;
    • Skotte, Niels H.;
    • Villanueva, Erika B.;
    • Østergaard, Michael E.;
    • Xiaofeng Gu;
    • Kordasiewicz, Holly B.;
    • Kay, Chris;
    • Cheung, Daphne;
    • Yuanyun Xie;
    • Waltl, Sabine;
    • Dal Cengio, Louisa;
    • Findlay-Black, Hailey;
    • Doty, Crystal N.;
    • Petoukhov, Eugenia;
    • Iworima, Diepiriye;
    • Slama, Ramy;
    • Ooi, Jolene;
    • Pouladi, Mahmoud A.;
    • Yang, X. William;
    • Swayze, Eric E.
    Publication type:
    Article
    20